Logo image of 0QF.DE

MODERNA INC (0QF.DE) Stock Fundamental Analysis

Europe - FRA:0QF - US60770K1079 - Common Stock

22.74 EUR
-1.2 (-4.99%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

3

Overall 0QF gets a fundamental rating of 3 out of 10. We evaluated 0QF against 79 industry peers in the Biotechnology industry. While 0QF seems to be doing ok healthwise, there are quite some concerns on its profitability. 0QF is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

0QF had negative earnings in the past year.
0QF had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: 0QF reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: 0QF reported negative operating cash flow in multiple years.
0QF.DE Yearly Net Income VS EBIT VS OCF VS FCF0QF.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

0QF has a Return On Assets (-24.17%) which is in line with its industry peers.
With a decent Return On Equity value of -30.89%, 0QF is doing good in the industry, outperforming 63.29% of the companies in the same industry.
Industry RankSector Rank
ROA -24.17%
ROE -30.89%
ROIC N/A
ROA(3y)-6.14%
ROA(5y)4.17%
ROE(3y)-7.66%
ROE(5y)6.83%
ROIC(3y)N/A
ROIC(5y)N/A
0QF.DE Yearly ROA, ROE, ROIC0QF.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

The Gross Margin of 0QF (68.32%) is comparable to the rest of the industry.
0QF's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for 0QF so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.55%
GM growth 5YN/A
0QF.DE Yearly Profit, Operating, Gross Margins0QF.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

6

2. Health

2.1 Basic Checks

0QF does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 0QF has been increased compared to 1 year ago.
0QF has more shares outstanding than it did 5 years ago.
The debt/assets ratio for 0QF has been reduced compared to a year ago.
0QF.DE Yearly Shares Outstanding0QF.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
0QF.DE Yearly Total Debt VS Total Assets0QF.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

0QF has an Altman-Z score of 3.40. This indicates that 0QF is financially healthy and has little risk of bankruptcy at the moment.
0QF has a Altman-Z score of 3.40. This is in the better half of the industry: 0QF outperforms 73.42% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that 0QF is not too dependend on debt financing.
The Debt to Equity ratio of 0QF (0.00) is better than 87.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.4
ROIC/WACCN/A
WACC9.31%
0QF.DE Yearly LT Debt VS Equity VS FCF0QF.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

0QF has a Current Ratio of 3.93. This indicates that 0QF is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.93, 0QF is in the better half of the industry, outperforming 68.35% of the companies in the same industry.
A Quick Ratio of 3.77 indicates that 0QF has no problem at all paying its short term obligations.
With a decent Quick ratio value of 3.77, 0QF is doing good in the industry, outperforming 68.35% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.93
Quick Ratio 3.77
0QF.DE Yearly Current Assets VS Current Liabilites0QF.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

More info and screens

5

3. Growth

3.1 Past

0QF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.04%, which is quite impressive.
0QF shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -39.05%.
0QF shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 122.01% yearly.
EPS 1Y (TTM)51.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.04%
Revenue 1Y (TTM)-39.05%
Revenue growth 3Y-44.04%
Revenue growth 5Y122.01%
Sales Q2Q%-41.08%

3.2 Future

The Earnings Per Share is expected to grow by 18.29% on average over the next years. This is quite good.
The Revenue is expected to grow by 18.42% on average over the next years. This is quite good.
EPS Next Y-7.53%
EPS Next 2Y6.31%
EPS Next 3Y12.25%
EPS Next 5Y18.29%
Revenue Next Year-40.24%
Revenue Next 2Y-18.76%
Revenue Next 3Y-6.42%
Revenue Next 5Y18.42%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
0QF.DE Yearly Revenue VS Estimates0QF.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
0QF.DE Yearly EPS VS Estimates0QF.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 10 -10 20

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

0QF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for 0QF. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
0QF.DE Price Earnings VS Forward Price Earnings0QF.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
0QF.DE Per share data0QF.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

0QF's earnings are expected to grow with 12.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.31%
EPS Next 3Y12.25%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for 0QF!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MODERNA INC

FRA:0QF (10/17/2025, 7:00:00 PM)

22.74

-1.2 (-4.99%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)10-30 2025-10-30/bmo
Inst Owners74.95%
Inst Owner ChangeN/A
Ins Owners2.55%
Ins Owner ChangeN/A
Market Cap8.85B
Analysts55.33
Price Target40.04 (76.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.41%
Min EPS beat(2)21.22%
Max EPS beat(2)29.6%
EPS beat(4)3
Avg EPS beat(4)36.52%
Min EPS beat(4)-6.26%
Max EPS beat(4)101.54%
EPS beat(8)6
Avg EPS beat(8)-7.95%
EPS beat(12)8
Avg EPS beat(12)0.84%
EPS beat(16)11
Avg EPS beat(16)4.98%
Revenue beat(2)1
Avg Revenue beat(2)11.48%
Min Revenue beat(2)-0.3%
Max Revenue beat(2)23.26%
Revenue beat(4)3
Avg Revenue beat(4)17.36%
Min Revenue beat(4)-0.3%
Max Revenue beat(4)46.04%
Revenue beat(8)7
Avg Revenue beat(8)31.8%
Revenue beat(12)9
Avg Revenue beat(12)25.64%
Revenue beat(16)12
Avg Revenue beat(16)20.85%
PT rev (1m)-1.7%
PT rev (3m)-4.65%
EPS NQ rev (1m)1.24%
EPS NQ rev (3m)-13%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)3.49%
Revenue NQ rev (1m)-0.74%
Revenue NQ rev (3m)-22.45%
Revenue NY rev (1m)0.2%
Revenue NY rev (3m)-8.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.35
P/FCF N/A
P/OCF N/A
P/B 1.1
P/tB 1.11
EV/EBITDA N/A
EPS(TTM)-6.46
EYN/A
EPS(NY)-6.93
Fwd EYN/A
FCF(TTM)-7.72
FCFYN/A
OCF(TTM)-5.95
OCFYN/A
SpS6.79
BVpS20.74
TBVpS20.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.17%
ROE -30.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.32%
FCFM N/A
ROA(3y)-6.14%
ROA(5y)4.17%
ROE(3y)-7.66%
ROE(5y)6.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.55%
GM growth 5YN/A
F-Score4
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 386.06%
Cap/Sales 26.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.93
Quick Ratio 3.77
Altman-Z 3.4
F-Score4
WACC9.31%
ROIC/WACCN/A
Cap/Depr(3y)261.63%
Cap/Depr(5y)224.68%
Cap/Sales(3y)14.96%
Cap/Sales(5y)10.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.04%
EPS Next Y-7.53%
EPS Next 2Y6.31%
EPS Next 3Y12.25%
EPS Next 5Y18.29%
Revenue 1Y (TTM)-39.05%
Revenue growth 3Y-44.04%
Revenue growth 5Y122.01%
Sales Q2Q%-41.08%
Revenue Next Year-40.24%
Revenue Next 2Y-18.76%
Revenue Next 3Y-6.42%
Revenue Next 5Y18.42%
EBIT growth 1Y35.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-0.33%
EBIT Next 3Y14.92%
EBIT Next 5Y18.54%
FCF growth 1Y-364.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1093.36%
OCF growth 3YN/A
OCF growth 5YN/A